AI assistant
ARIX BIOSCIENCE PLC Remuneration Information 2022
4968_def-14a_2022-12-01_2a2827b8-627a-4f2a-91d0-cef197e1b4ad.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 2304I
Arix Bioscience Plc
01 December 2022
Arix Bioscience plc
("Company")
PDMR notification & Director Shareholding
The Company announces the annual award of nil cost options to CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period from 1 January 2022 to 31 December 2024 in accordance with the Company's Executive Incentive Plan ("EIP") as disclosed in the Company's Remuneration Policy ("Policy"). Vested Shares are subject to a further two year holding period, as set out in the Policy.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Robert Lyne | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Executive Officer | |||
| b) | Initial notification /Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Arix Bioscience plc | |||
| b) | LEI | 213800OVT3AHQCXNIX43 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | |||
| Identification code | GB00BD045071 | ||||
| b) | Nature of the transaction | Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| Nil | 636,792 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume | N/A (Single Transaction) | ||||
| - Price | N/A (Single Transaction) | ||||
| e) | Date of the transaction | 30 November 2022 | |||
| f) | Place of the transaction | Outside a trading venue |
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDFLBBLLLXFBQ